SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH L impact

ACAD DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

ACAD DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

ACADCHMPDAYBU

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.